Thrombo-inflammation
Cardiovascular diseases are a major cause of morbidity and mortality and disproportionately affects ethnic minority groups and those socioeconomically deprived. The interplay between inflammation and thrombosis (thrombo-inflammation) plays a critical role in nearly all vascular and heart diseases, and represents a major target for clinical interventions. Moreover, vascular events are a significant driver of prognosis across all chronic inflammatory diseases. Our thrombo-inflammation theme will improve our ability to intercede in clotting whilst avoiding excess bleeding, target underlying inflammatory processes, identify novel biomarkers of thrombo-inflammatory disease, and use artificial intelligence (AI) and innovative trial designs to translate research to better patient care.
Theme Leads
Professor Steve Watson
Professor Dipak Kotecha
Related news
Patients with Atrial High-Rate Episodes should not be treated with anticoagulant, trial finds
A trial involving Birmingham researchers showed that patients with atrial high-rate episodes (AHREs) detected by implanted
New grant award to find better treatments for thrombo-inflammatory diseases
A new funding injection will further Birmingham research into thrombo-inflammatory diseases, with the aim of identifying
First clinical trial evaluating glenzocimab for heart attacks approved
The University of Birmingham and Acticor Biotech announce full regulatory approval of the LIBERATE clinical study.
